Neion Bio, a biotechnology company revolutionizing the production of biologic medicines, today announced the close of an oversubscribed $23 million Series A financing to further advance its novel ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果